Stockscreener 앱 받기
55.68
2.84%
1.54
시간 외 거래:
55.68
전일 마감가:
$54.14
열려 있는:
$54.14
하루 거래량:
171.28K
Relative Volume:
1.22
시가총액:
$615.80M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+2.83%
1개월 성능:
+48.40%
6개월 성능:
+149.24%
1년 성능:
+0.00%
1일 변동 폭
$52.36
$58.22
1주일 범위
$50.82
$58.22
52주 변동 폭
$11.17
$58.22
Palvella Therapeutics Inc Stock (PVLA) Company Profile
명칭
Palvella Therapeutics Inc
전화
(484) 253-1461
주소
125 STRAFFORD AVE, WAYNE
PVLA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PVLA
Palvella Therapeutics Inc
|
55.68 | 598.77M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Palvella Therapeutics Inc Stock (PVLA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 개시 | Raymond James | Outperform |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-04-09 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-26 | 개시 | Stifel | Buy |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2025-02-20 | 개시 | Canaccord Genuity | Buy |
| 2025-02-05 | 개시 | TD Cowen | Buy |
| 2024-12-26 | 개시 | H.C. Wainwright | Buy |
| 2024-12-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-03-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-07-30 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-05-14 | 개시 | Robert W. Baird | Outperform |
| 2018-03-19 | 개시 | Evercore ISI | Outperform |
| 2018-03-19 | 개시 | Jefferies | Buy |
| 2018-01-16 | 재확인 | H.C. Wainwright | Buy |
| 2017-05-30 | 개시 | Rodman & Renshaw | Buy |
| 2016-08-05 | 재개 | ROTH Capital | Buy |
| 2015-08-12 | 개시 | JMP Securities | Mkt Outperform |
| 2015-07-27 | 개시 | Oppenheimer | Outperform |
| 2015-07-22 | 개시 | ROTH Capital | Buy |
모두보기
Palvella Therapeutics Inc 주식(PVLA)의 최신 뉴스
Statistical indicators supporting Palvella Therapeutics Inc.’s strengthInflation Watch & Fast Exit and Entry Strategy Plans - Newser
Using flow based indicators on Palvella Therapeutics Inc.2025 Bull vs Bear & Safe Swing Trade Setups - Newser
Does Palvella Therapeutics Inc. have strong EBITDA marginsMarket Sentiment Report & Technical Pattern Based Buy Signals - خودرو بانک
Palvella Therapeutics Inc. stock outlook for YEAR2025 Technical Patterns & AI Driven Price Predictions - Newser
Using RSI to spot recovery in Palvella Therapeutics Inc.2025 Major Catalysts & Real-Time Price Movement Reports - Newser
Palvella Therapeutics Inc. stock retracement – recovery analysis2025 Macro Impact & Free Daily Entry Point Trade Alerts - Newser
Is Palvella Therapeutics Inc. stock ready for a breakoutJuly 2025 Analyst Calls & Proven Capital Preservation Methods - Newser
Applying Elliott Wave Theory to Palvella Therapeutics Inc.Earnings Summary Report & Long-Term Capital Growth Ideas - Newser
News impact scoring models applied to Palvella Therapeutics Inc.Insider Selling & Weekly Return Optimization Plans - Newser
What indicators show strength in Palvella Therapeutics Inc.July 2025 Price Swings & High Win Rate Trade Tips - Newser
Using portfolio simulators with Palvella Therapeutics Inc. includedBond Market & Safe Capital Growth Tips - Newser
Detecting price anomalies in Palvella Therapeutics Inc. with AIWatch List & Stepwise Trade Signal Guides - Newser
What is Palvella Therapeutics Inc. s debt to equity ratioBond Market & Low Volatility Stock Recommendations - خودرو بانک
Key metrics from Palvella Therapeutics Inc.’s quarterly dataWeekly Risk Summary & Precise Trade Entry Recommendations - Newser
Using data models to predict Palvella Therapeutics Inc. stock movementBond Market & Free Community Consensus Stock Picks - Newser
Does Palvella Therapeutics Inc. fit your quant trading modelTrade Signal Summary & Long-Term Safe Investment Plans - Newser
Palvella Therapeutics Appoints David W. Osborne, Ph.D. as Chief Innovation Officer - citybiz
Palvella Therapeutics shares fall 2.52% intraday after appointing new chief innovation officer. - AInvest
Palvella Therapeutics Inc.’s volatility index tracking explainedMarket Volume Summary & Reliable Momentum Entry Alerts - Newser
Can you recover from losses in Palvella Therapeutics Inc.2025 Top Gainers & Daily Volume Surge Signals - Newser
Palvella Therapeutics appoints David Osborne as chief innovation officer - Investing.com
Palvella Therapeutics appoints David Osborne as chief innovation officer By Investing.com - Investing.com Australia
Palvella Therapeutics Accelerates U.S. Launch Planning - TipRanks
Palvella Therapeutics Strengthens Leadership with Appointment of Accomplished Scientist and Biopharmaceutical Executive David W. Osborne, Ph.D. as Chief Innovation Officer - The Manila Times
Palvella Therapeutics reports Q2 FY23 revenue of $0.4mln, down 96% YoY. - AInvest
Palvella Therapeutics Strengthens Leadership with - GlobeNewswire
David Osborne Appointed Chief Innovation Officer at Palvella Therapeutics - AInvest
Former Arcutis CTO with 52 US Patents Joins Palvella Therapeutics to Expand Rare Skin Disease Platform - Stock Titan
Is this a good reentry point in Palvella Therapeutics Inc.Market Trend Review & Free Real-Time Volume Trigger Notifications - Newser
What high frequency data says about Palvella Therapeutics Inc.July 2025 Macro Moves & AI Forecasted Stock Moves - Newser
Is Palvella Therapeutics Inc. showing signs of accumulation2025 Earnings Impact & Weekly Top Gainers Trade List - Newser
Is Palvella Therapeutics Inc. stock poised for growth2025 Market WrapUp & Fast Momentum Stock Entry Tips - Newser
How sensitive is Palvella Therapeutics Inc. to inflationMarket Sentiment Report & Weekly Chart Analysis and Guides - خودرو بانک
Quantitative breakdown of Palvella Therapeutics Inc. recent moveRate Cut & Free Fast Gain Swing Trade Alerts - Newser
Multi asset correlation models including Palvella Therapeutics Inc.Weekly Stock Report & AI Enhanced Trade Execution Alerts - Newser
What is the next catalyst for Palvella Therapeutics Inc.2025 Breakouts & Breakdowns & AI Enhanced Trading Alerts - خودرو بانک
Palvella Therapeutics Inc (PVLA) 재무 분석
Palvella Therapeutics Inc (PVLA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Palvella Therapeutics Inc 주식 (PVLA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| JENKINS GEORGE M | Director |
Apr 09 '25 |
Buy |
20.13 |
2,500 |
50,325 |
183,171 |
| JENKINS GEORGE M | Director |
Dec 18 '24 |
Buy |
12.93 |
4,000 |
51,720 |
180,671 |
1.40%
자본화:
|
볼륨(24시간):